News

Availability of XYLLOMAC® 1g, powder for solution for injection/IM-IV infusion, box of 1, in pharmacies

edv2023-12-13T19:12:09+00:00December 13, 2023|

Commercialisation of LORAZEPAM XILMAC® 4mg/ml, solution for injection, in France

edv2023-11-07T12:26:09+00:00November 6, 2023|

Availability of Ceplene® 0.5mg/0.5ml, solution for injection (Histamine dihydrochloride), in Germany and Austria

edv2023-10-09T15:15:57+00:00October 9, 2023|

Availability of Prostaphlin® 1000 mg for Czech market

edv2023-01-30T16:38:10+00:00January 26, 2023|

Commercialization of amoxicilline in Ireland

edv2023-01-16T16:47:29+00:00January 16, 2023|

THE LABORATOIRES DELBERT ANNOUNCES A SERVICES AGREEMENT WITH IBI

edv2022-11-30T10:35:50+00:00November 30, 2022|

Acquisition de TERALITHE® par les Laboratoires Delbert

edv2022-07-05T07:46:12+00:00July 5, 2022|

Acquisition of TERALITHE® by the Laboratoires Delbert

edv2022-05-18T13:36:06+00:00May 17, 2022|

Laboratoires Delbert – Help to Ukraine

edv2022-04-14T10:27:27+00:00April 14, 2022|

Augmentin® injectable devient Levmentin® : informations et dates de mise à disposition

edv2022-03-07T11:25:27+00:00March 7, 2022|